Dr. Richard Joseph Nowak, MD

Dr. Nowak practices at Yale Medicine in New Haven, Connecticut.

Dr. Nowak's NPI, 1730346818, was assigned on May 17, 2008. Dr. Nowak holds Connecticut license AY26291556842.

Dr. Nowak's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Nowak's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Nowak is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Nowak to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nowak practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nowak's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Nowak is licensed in Connecticut.

CMS data shows 240 Medicare services from Dr. Nowak across 6 procedure codes in 2024, for 127 Medicare patients. Medicare paid $25,541 for them. Every service was in an office.

CMS counts 127 Medicare patients who saw Dr. Nowak in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nowak's median patient age at 71, with 44% women.

In 2024, Dr. Nowak wrote 1,825 Medicare Part D claims for 214 patients. 83% of them were for generic drugs. CMS names the drug for 1,755 of them, across 16 drugs with 11 or more claims each, at $3,893,662 in total drug cost. In 2023, CMS named 1,674 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Nowak for performance year 2024, reported as part of a group. Dr. Nowak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nowak as offering telehealth.

Dmand AI links 135 papers to Dr. Nowak, published from 2010 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Myasthenia Gravis, Autoantibodies and Receptors, Cholinergic. Dr. Nowak has published most often in J Neurol Sci. Dr. Nowak's most frequent co-authors are Alan Maisel, MD, Bhaskar Roy, MBBS and Chad M. Cannon, MD.

Dmand AI links Dr. Nowak to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Myasthenia Gravis, Neuromuscular Junction Diseases and Miller Fisher Syndrome. Grifols Therapeutics LLC sponsors the most, 2. Open Payments lists research payments to Dr. Nowak that name 1 trial.

CMS Open Payments shows 189 general payments to Dr. Nowak from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Alexion Pharmaceuticals, Inc. paid the most, $74,086. It also lists 6 research payments totaling $13,081 from 2019 to 2025, naming 1 clinical trial.